Editing MPEP 608
From wikilawschool.net. Wiki Law School does not provide legal advice. For educational purposes only.
The edit can be undone. Please check the comparison below to verify that this is what you want to do, and then publish the changes below to finish undoing the edit.
Latest revision | Your text | ||
Line 931: | Line 931: | ||
====608.01(a) Arrangement of Application==== | ====608.01(a) Arrangement of Application==== | ||
37 CFR 1.77. Arrangement of application elements. | |||
(a)The elements of the application, if applicable, should | (a)The elements of the application, if applicable, should | ||
appear in the following order: | appear in the following order: | ||
(1)Utility application transmittal form. | |||
(2)Fee transmittal form. | |||
(3)Application data sheet (see § 1.76). | |||
(4)Specification. | |||
(5)Drawings. | |||
(6)Executed oath or declaration. | |||
(b)The specification should include the following sections | (b)The specification should include the following sections | ||
in order: | in order: | ||
(1)Title of the invention, which may be accompanied | |||
by an introductory portion stating the name, citizenship, and residence | by an introductory portion stating the name, citizenship, and residence | ||
of the applicant (unless included in the application data | of the applicant (unless included in the application data | ||
sheet). | sheet). | ||
(2)Cross-reference to related applications (unless | |||
included in the application data sheet). | |||
(3)Statement regarding federally sponsored research | |||
or development. | |||
(4)The names of the parties to a joint research agreement. | |||
(5)Reference to a “Sequence Listing,” a table, or a computer | |||
program listing appendix submitted on a compact disc and | program listing appendix submitted on a compact disc and | ||
an incorporation-by-reference of the material on the compact disc | an incorporation-by-reference of the material on the compact disc | ||
(see § 1.52(e)(5)). The total number of compact discs including | (see § 1.52(e)(5)). The total number of compact discs including | ||
duplicates and the files on each compact disc shall be specified. | duplicates and the files on each compact disc shall be specified. | ||
(6)Background of the invention. | |||
(7)Brief summary of the invention. | |||
(8)Brief description of the several views of the drawing. | |||
(9)Detailed description of the invention. | |||
(10)A claim or claims. | |||
(11)Abstract of the disclosure. | |||
(12)“Sequence Listing,” if on paper (see §§ | |||
1.821through 1.825). | |||
(c)The text of the specification sections defined in paragraphs | (c)The text of the specification sections defined in paragraphs | ||
Line 987: | Line 998: | ||
be preceded by a section heading in uppercase and without underlining | be preceded by a section heading in uppercase and without underlining | ||
or bold type. | or bold type. | ||
For design patent specification, see MPEP § | For design patent specification, see MPEP § | ||
Line 1,036: | Line 1,045: | ||
The total number of compact discs including duplicates | The total number of compact discs including duplicates | ||
and the files on each compact disc must be specified. | and the files on each compact disc must be specified. | ||
(F)Background of the Invention. | (F)Background of the Invention. | ||
(1)Field of the Invention. | |||
(2)Description of the related art including | |||
information disclosed under 37 CFR 1.97 and 1.98. | information disclosed under 37 CFR 1.97 and 1.98. | ||
(G)Brief Summary of the Invention. | (G)Brief Summary of the Invention. | ||
Line 1,055: | Line 1,065: | ||
(K)Abstract of the Disclosure. | (K)Abstract of the Disclosure. | ||
(L) | (L)“Sequence Listing,” if on paper (See 37 | ||
CFR 1.821-1.825). | CFR | ||
1.821-1.825). | |||
Applicant (typically a pro se) may be advised of the | |||
proper arrangement by using Form Paragraph 6.01 or | |||
6.02. | |||
¶ 6.01 Arrangement of the Sections of the Specification in | |||
a Utility Application | |||
The following guidelines illustrate the preferred layout for the | |||
specification of a utility application. These guidelines are suggested | |||
for the applicant’s use. | |||
Arrangement of the Specification | |||
As provided in 37 CFR 1.77(b), the specification of a utility | |||
application should include the following sections in order. Each | |||
of the lettered items should appear in upper case, without underlining | |||
or bold type, as a section heading. If no text follows the section | |||
heading, the phrase “Not Applicable” should follow the | |||
section heading: | |||
(a) TITLE OF THE INVENTION. | |||
(b) CROSS-REFERENCE TO RELATED APPLICATIONS. | |||
(c) STATEMENT REGARDING FEDERALLY SPONSORED | |||
RESEARCH OR DEVELOPMENT. | |||
(d) THE NAMES OF THE PARTIES TO A JOINT | |||
RESEARCH AGREEMENT. | |||
(e) INCORPORATION-BY-REFERENCE OF MATERIAL | |||
SUBMITTED ON A COMPACT DISC. | |||
(f) BACKGROUND OF THE INVENTION. | |||
(1) Field of the Invention. | |||
(2) Description of Related Art including information disclosed | |||
under 37 CFR 1.97 and 1.98. | |||
(g) BRIEF SUMMARY OF THE INVENTION. | |||
(h) BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF | |||
THE DRAWING(S). | |||
(i) DETAILED DESCRIPTION OF THE INVENTION. | |||
(j) CLAIM OR CLAIMS (commencing on a separate sheet). | |||
(k) ABSTRACT OF THE DISCLOSURE (commencing on a | |||
separate sheet). | |||
(l) SEQUENCE LISTING. (See MPEP § 2424 and 37 CFR | |||
1.821-1.825. A “Sequence Listing” is required on paper if the | |||
application discloses a nucleotide or amino acid sequence as | |||
defined in 37 CFR 1.821(a) and if the required “Sequence Listing” | |||
is not submitted as an electronic document on compact disc.) | |||
Examiner Note: | |||
For the arrangement of the sections of the specification in a | |||
design application, see 37 CFR 1.154(b). Form paragraph 15.05may be used for a design application. For the arrangement of the | |||
sections of the specification in a plant application, see 37 CFR | |||
1.163(c). For the requirements of the specification in a reissue | |||
application, see 37 CFR 1.173(a)(1). | |||
¶ 6.02 Content of Specification | |||
Content of Specification | |||
(a) TITLE OF THE INVENTION: See 37 CFR 1.72(a) and | |||
MPEP § 606. The title of the invention should be placed at the top | |||
of the first page of the specification unless the title is provided in | |||
an application data sheet. The title of the invention should be brief | |||
but technically accurate and descriptive, preferably from two to | |||
seven words. It may not contain more than 500 characters. | |||
(b) CROSS-REFERENCES TO RELATED APPLICATIONS: | |||
See 37 CFR 1.78 and MPEP § 201.11. | |||
(c) STATEMENT REGARDING FEDERALLY SPONSORED | |||
RESEARCH OR DEVELOPMENT: See MPEP § 310. | |||
(d) THE NAMES OF THE PARTIES TO A JOINT | |||
RESEARCH AGREEMENT. See 37 CFR 1.71(g). | |||
(e) INCORPORATION-BY-REFERENCE OF MATERIAL | |||
SUBMITTED ON A COMPACT DISC: The specification is | |||
required to include an incorporation-by-reference of electronic | |||
documents that are to become part of the permanent United States | |||
Patent and Trademark Office records in the file of a patent application. | |||
See 37 CFR 1.52(e) and MPEP § 608.05. Computer program | |||
listings (37 CFR 1.96(c)), “Sequence Listings” (37 CFR | |||
1.821(c)), and tables having more than 50 pages of text were permitted | |||
as electronic documents on compact discs beginning on | |||
September 8, 2000. | |||
(f) BACKGROUND OF THE INVENTION: See MPEP § | |||
608.01(c). The specification should set forth the Background of | |||
the Invention in two parts: | |||
(1) Field of the Invention: A statement of the field of art to | |||
which the invention pertains. This statement may include a paraphrasing | |||
of the applicable U.S. patent classification definitions of | |||
the subject matter of the claimed invention. This item may also be | |||
titled “Technical Field.” | |||
(2) Description of the Related Art including information disclosed | |||
under 37 CFR 1.97 and 37 CFR 1.98: A description of the | |||
related art known to the applicant and including, if applicable, references | |||
to specific related art and problems involved in the prior | |||
art which are solved by the applicant’s invention. This item may | |||
also be titled “Background Art.” | |||
(g) BRIEF SUMMARY OF THE INVENTION: See MPEP § | |||
608.01(d). A brief summary or general statement of the invention | |||
as set forth in 37 CFR 1.73. The summary is separate and distinct | |||
from the abstract and is directed toward the invention rather than | |||
the disclosure as a whole. The summary may point out the advantages | |||
of the invention or how it solves problems previously existent | |||
in the prior art (and preferably indicated in the Background of | |||
the Invention). In chemical cases it should point out in general | |||
terms the utility of the invention. If possible, the nature and gist of | |||
the invention or the inventive concept should be set forth. Objects | |||
of the invention should be treated briefly and only to the extent | |||
that they contribute to an understanding of the invention. | |||
(h) BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF | |||
THE DRAWING(S): See MPEP § 608.01(f). A reference to and | |||
brief description of the drawing(s) as set forth in 37 CFR 1.74. | |||
(i) DETAILED DESCRIPTION OF THE INVENTION: See | |||
MPEP § 608.01(g). A description of the preferred embodiment(s) | |||
of the invention as required in 37 CFR 1.71. The description | |||
should be as short and specific as is necessary to describe the | |||
invention adequately and accurately. Where elements or groups of | |||
elements, compounds, and processes, which are conventional and | |||
generally widely known in the field of the invention described, | |||
and their exact nature or type is not necessary for an understanding | |||
and use of the invention by a person skilled in the art, they | |||
should not be described in detail. However, where particularly | |||
complicated subject matter is involved or where the elements, | |||
compounds, or processes may not be commonly or widely known | |||
in the field, the specification should refer to another patent or | |||
readily available publication which adequately describes the subject | |||
matter. | |||
(j) CLAIM OR CLAIMS: See 37 CFR 1.75 and MPEP § | |||
608.01(m). The claim or claims must commence on a separate | |||
sheet or electronic page (37 CFR 1.52(b)(3)). Where a claim sets | |||
forth a plurality of elements or steps, each element or step of the | |||
claim should be separated by a line indentation. There may be plural | |||
indentations to further segregate subcombinations or related | |||
steps. See 37 CFR 1.75 and MPEP 608.01(i)-(p). | |||
(k) ABSTRACT OF THE DISCLOSURE: See 37 CFR | |||
1.72(b) and MPEP § 608.01(b). A brief narrative of the disclosure | |||
as a whole in a single paragraph of 150 words or less commencing | |||
on a separate sheet following the claims. In an international application | |||
which has entered the national stage (37 CFR 1.491(b)), the | |||
applicant need not submit an abstract commencing on a separate | |||
sheet if an abstract was published with the international application | |||
under PCT Article 21. The abstract that appears on the cover | |||
page of the pamphlet published by the International Bureau (IB) | |||
of the World Intellectual Property Organization (WIPO) is the | |||
abstract that will be used by the USPTO. See MPEP § 1893.03(e). | |||
(l) SEQUENCE LISTING: See 37 CFR 1.821-1.825 and | |||
MPEP §§ 2421-2431. The requirement for a sequence listing | |||
applies to all sequences disclosed in a given application, whether | |||
the sequences are claimed or not. See MPEP § 2421.02. | |||
Examiner Note: | |||
In this paragraph an introductory sentence will be necessary. | |||
This paragraph is intended primarily for use in pro se applications. | |||
608.01(b)Abstract of the Disclosure [R-3] | |||
37 CFR 1.72. Title and abstract. | |||
(b)A brief abstract of the technical disclosure in the specification | (b)A brief abstract of the technical disclosure in the specification | ||
must commence on a separate sheet, preferably following | must commence on a separate sheet, preferably following | ||
the claims, under the heading | the claims, under the heading “Abstract” or “Abstract of the Disclosure.” | ||
The sheet or sheets presenting the abstract may not | The sheet or sheets presenting the abstract may not | ||
include other parts of the application or other material. The | include other parts of the application or other material. The | ||
Line 1,072: | Line 1,280: | ||
public generally to determine quickly from a cursory inspection | public generally to determine quickly from a cursory inspection | ||
the nature and gist of the technical disclosure. | the nature and gist of the technical disclosure. | ||
The Office of Initial Patent Examination (OIPE) | The Office of Initial Patent Examination (OIPE) | ||
will review all applications filed under 35 U.S.C. | will review all applications filed under 35 U.S.C. | ||
111(a) for compliance with 37 CFR 1.72 and will | 111(a) for compliance with 37 CFR 1.72 and will | ||
require an abstract, if one has not been filed. | require an abstract, if one has not been filed. In all | ||
other applications which lack an abstract, the examiner | |||
in the first Office action should require the submission | |||
of an abstract directed to the technical | |||
disclosure in the specification. See Form Paragraph | |||
6.12 (below). Applicants may use either “Abstract” or | |||
“Abstract of the Disclosure” as a heading. | |||
If the abstract contained in the application does not | |||
comply with the guidelines, the examiner should point | |||
out the defect to the applicant in the first Office | |||
action, or at the earliest point in the prosecution that | |||
the defect is noted, and require compliance with the | |||
guidelines. Since the abstract of the disclosure has | |||
been interpreted to be a part of the specification for | |||
the purpose of compliance with paragraph 1 of 35 | |||
U.S.C. 112 (In re Armbruster, 512 F.2d 676, 678-79, | |||
185 USPQ 152, 154 (CCPA 1975)), it would ordinarily | |||
be preferable that the applicant make the necessary | |||
changes to the abstract to bring it into | |||
compliance with the guidelines. See Form Paragraphs | |||
6.13-6.16 (below). | |||
Replies to such actions requiring either a new | |||
abstract or amendment to bring the abstract into compliance | |||
with the guidelines should be treated under 37 | |||
CFR 1.111(b) practice like any other formal matter. | |||
Any submission of a new abstract or amendment to an | |||
existing abstract should be carefully reviewed for | |||
introduction of new matter, 35 | |||
U.S.C. 132, MPEP § | |||
608.04. | |||
Upon passing the application to issue, the examiner | Upon passing the application to issue, the examiner | ||
Line 1,089: | Line 1,326: | ||
revisions by a formal examiner’s amendment after | revisions by a formal examiner’s amendment after | ||
obtaining applicant’s authorization (see MPEP § | obtaining applicant’s authorization (see MPEP § | ||
1302.04 | 1302.04 rather than issuing an Ex parte Quayle action | ||
requiring applicant to make the necessary revisions. | requiring applicant to make the necessary revisions. | ||
Line 1,096: | Line 1,333: | ||
the abstract will be printed on the patent. | the abstract will be printed on the patent. | ||
GUIDELINES FOR THE PREPARATION OF PATENT ABSTRACTS | GUIDELINES FOR THE PREPARATION OF | ||
PATENT ABSTRACTS | |||
A.Background | A.Background | ||
Line 1,117: | Line 1,355: | ||
disclosure of the patent and should include that | disclosure of the patent and should include that | ||
which is new in the art to which the invention pertains. | which is new in the art to which the invention pertains. | ||
If the patent is of a basic nature, the entire technical | If the patent is of a basic nature, the entire technical | ||
disclosure may be new in the art, and the abstract | disclosure may be new in the art, and the abstract | ||
should be directed to the entire disclosure. | should be directed to the entire disclosure. | ||
If the patent is in the nature of an improvement in | If the patent is in the nature of an improvement in | ||
Line 1,136: | Line 1,380: | ||
or alternatives, the abstract should mention by | or alternatives, the abstract should mention by | ||
way of example the preferred modification or alternative. | way of example the preferred modification or alternative. | ||
The abstract should not refer to purported merits or | The abstract should not refer to purported merits or | ||
Line 1,152: | Line 1,397: | ||
compounds or compositions, the general nature of the | compounds or compositions, the general nature of the | ||
compound or composition should be given as well as | compound or composition should be given as well as | ||
the use thereof, e.g., | the use thereof, e.g., “The compounds are of the class | ||
of alkyl benzene sulfonyl ureas, useful as oral anti- | of alkyl benzene sulfonyl ureas, useful as oral anti- | ||
diabetics. | diabetics.” Exemplification of a species could be | ||
illustrative of members of the class. For processes, the | illustrative of members of the class. For processes, the | ||
type reaction, reagents and process conditions should | type reaction, reagents and process conditions should | ||
Line 1,164: | Line 1,409: | ||
The abstract must commence on a separate sheet, | The abstract must commence on a separate sheet, | ||
preferably following the claims, under the heading | preferably following the claims, under the heading | ||
“Abstract” or “Abstract of the Disclosure.” The sheet | |||
or sheets presenting the abstract may not include other | or sheets presenting the abstract may not include other | ||
parts of the application or other material. | parts of the application or other material. Form paragraph | ||
6.16.01 (below) may be used if the abstract | |||
does not commence on a separate sheet. Note that the | |||
abstract for a national stage application filed under 35 | |||
U.S.C. 371 may be found on the front page of the | |||
Patent Cooperation Treaty publication (i.e., pamphlet). | |||
See MPEP § 1893.03(e). | |||
The abstract should be in narrative form and generally | The abstract should be in narrative form and generally | ||
limited to a single paragraph within the range of | limited to a single paragraph within the range of | ||
50 to 150 words. The abstract should not exceed | 50 to 150 words. The abstract should not exceed | ||
15 lines of text. | 15 lines of text. Abstracts exceeding 15 lines | ||
should | of text should be checked to see that it does not | ||
exceed 150 words in length since the space provided | |||
for the abstract on the computer tape by the printer is | |||
limited. If the abstract cannot be placed on the computer | |||
tape because of its excessive length, the application | |||
will be returned to the examiner for preparation | |||
of a shorter abstract. The form and legal phraseology | |||
often used in patent claims, such as “means” and | |||
“said,” should be avoided. The abstract should sufficiently | |||
describe the disclosure to assist readers in | |||
deciding whether there is a need for consulting the | |||
full patent text for details. | |||
The language should be clear and concise and | |||
should not repeat information given in the title. It | |||
should avoid using phrases which can be implied, | |||
such as, “This disclosure concerns,” “The disclosure | |||
defined by this invention,” “This disclosure | |||
describes,” etc. | |||
D.Responsibility | |||
Preparation of the abstract is the responsibility of | |||
the applicant. Background knowledge of the art and | |||
an appreciation of the applicant’s contribution to the | |||
art are most important in the preparation of the | |||
abstract. The review of the abstract for compliance | |||
with these guidelines, with any necessary editing and | |||
revision on allowance of the application, is the | |||
responsibility of the examiner. | |||
E.Sample Abstracts | |||
(1) A heart valve which has an annular valve body | |||
defining an orifice and a plurality of struts forming | |||
a pair of cages on opposite sides of the orifice. A | |||
spherical closure member is captively held within | |||
the cages and is moved by blood flow between | |||
open and closed positions in check valve fashion. | |||
A slight leak or backflow is provided in the closed | |||
position by making the orifice slightly larger than | |||
the closure member. Blood flow is maximized in | |||
the open position of the valve by providing an | |||
inwardly convex contour on the orifice-defining | |||
surfaces of the body. An annular rib is formed in a | |||
channel around the periphery of the valve body to | |||
anchor a suture ring used to secure the valve | |||
within a heart. | |||
(2) A method for sealing whereby heat is applied | |||
to seal, overlapping closure panels of a folding box | |||
made from paperboard having an extremely thin | |||
coating of moisture-proofing thermoplastic material | |||
on opposite surfaces. Heated air is directed at | |||
the surfaces to be bonded, the temperature of the | |||
air at the point of impact on the surfaces being | |||
above the char point of the board. The duration of | |||
application of heat is made so brief, by a corresponding | |||
high rate of advance of the boxes | |||
through the air stream, that the coating on the | |||
reverse side of the panels remains substantially | |||
non-tacky. The bond is formed immediately after | |||
heating within a period of time for any one surface | |||
point less than the total time of exposure to heated | |||
air of that point. Under such conditions the heat | |||
applied to soften the thermoplastic coating is dissipated | |||
after completion of the bond by absorption | |||
into the board acting as a heat sink without the | |||
need for cooling devices. | |||
(3) Amides are produced by reacting an ester of a | |||
carbonized acid with an amine, using as catalyst an | |||
dioxide of an alkali metal. The ester is first heated | |||
to at least 75°C under a pressure of no more than | |||
500 mm. of mercury to remove moisture and acid | |||
gases which would prevent the reaction, and then | |||
converted to an amide without heating to initiate | |||
the reaction. | |||
¶ 6.12 Abstract Missing (Background) | |||
This application does not contain an abstract of the disclosure | |||
as required by 37 CFR 1.72(b). An abstract on a separate sheet is | |||
required. | |||
Examiner Note: | |||
1.For pro se applicant, consider form paragraphs 6.14 to 6.16. | |||
2.This form paragraph should not be used during the national | |||
stage prosecution of international applications (“371 applications”) | |||
if an abstract was published with the international application | |||
under PCT Article 21. | |||
¶ 6.13 Abstract Objected To: Minor Informalities | |||
The abstract of the disclosure is objected to because [1]. Correction | |||
is required. See MPEP § 608.01(b). | |||
Examiner Note: | |||
In bracket 1, indicate the informalities that should be corrected. | |||
Use this paragraph for minor informalities such as the inclusion of | |||
legal phraseology, undue length, etc. | |||
¶ 6.14 Abstract of the Disclosure: Content | |||
Applicant is reminded of the proper content of an abstract of | |||
the disclosure. | |||
A patent abstract is a concise statement of the technical disclosure | |||
of the patent and should include that which is new in the art | |||
to which the invention pertains. If the patent is of a basic nature, | |||
the entire technical disclosure may be new in the art, and the | |||
abstract should be directed to the entire disclosure. If the patent is | |||
in the nature of an improvement in an old apparatus, process, | |||
product, or composition, the abstract should include the technical | |||
disclosure of the improvement. In certain patents, particularly | |||
those for compounds and compositions, wherein the process for | |||
making and/or the use thereof are not obvious, the abstract should | |||
set forth a process for making and/or use thereof. If the new technical | |||
disclosure involves modifications or alternatives, the | |||
abstract should mention by way of example the preferred modification | |||
or alternative. | |||
The abstract should not refer to purported merits or speculative | |||
applications of the invention and should not compare the invention | |||
with the prior art. | |||
Where applicable, the abstract should include the following: | |||
(1) if a machine or apparatus, its organization and operation; | |||
(2) if an article, its method of making; | |||
(3) if a chemical compound, its identity and use; | |||
(4) if a mixture, its ingredients; | |||
(5) if a process, the steps. | |||
Extensive mechanical and design details of an apparatus | |||
should not be included in the abstract. | |||
Examiner Note: | |||
See form paragraph 6.16. | |||
¶ 6.15 Abstract of the Disclosure: Chemical Cases | |||
Applicant is reminded of the proper content of an abstract of | |||
the disclosure. | |||
In chemical patent abstracts for compounds or compositions, | |||
the general nature of the compound or composition should be | |||
given as well as its use, e.g., “The compounds are of the class of | |||
alkyl benzene sulfonyl ureas, useful as oral anti-diabetics.” | |||
Exemplification of a species could be illustrative of members of | |||
the class. For processes, the type reaction, reagents and process | |||
conditions should be stated, generally illustrated by a single | |||
example unless variations are necessary. | |||
Complete revision of the content of the abstract is required on a | |||
separate sheet. | |||
¶ 6.16 Abstract of the Disclosure: Language | |||
Applicant is reminded of the proper language and format for an | |||
abstract of the disclosure. | |||
The abstract should be in narrative form and generally limited | |||
to a single paragraph on a separate sheet within the range of 50 to | |||
150 words. It is important that the abstract not exceed 150 words | |||
in length since the space provided for the abstract on the computer | |||
tape used by the printer is limited. The form and legal phraseology | |||
often used in patent claims, such as “means” and “said,” | |||
should be avoided. The abstract should describe the disclosure | |||
sufficiently to assist readers in deciding whether there is a need | |||
for consulting the full patent text for details. | |||
The language should be clear and concise and should not | |||
repeat information given in the title. It should avoid using phrases | |||
which can be implied, such as, “The disclosure concerns,” “The | |||
disclosure defined by this invention,” “The disclosure describes,” | |||
etc. | |||
Examiner Note: | |||
See also form paragraph 6.14. | |||
¶ 6.16.01 Abstract of the Disclosure: Placement | |||
The abstract of the disclosure does not commence on a separate | |||
sheet in accordance with 37 CFR 1.52(b)(4). A new abstract of | |||
the disclosure is required and must be presented on a separate | |||
sheet, apart from any other text. | |||
Examiner Note: | |||
1.This paragraph should only be used for applications filed on | |||
or after September 23, 1996. | |||
2.37 CFR 1.72(b) requires that the abstract be set forth on a | |||
separate sheet. This requirement applies to amendments to the | |||
abstract as well as to the initial filing of the application. | |||
3.This form paragraph should not be used during the national | |||
stage prosecution of international applications (“371 applications”) | |||
if an abstract was published with the international application | |||
under PCT Article 21. | |||
608.01(c)Background of the Invention | |||
The Background of the Invention ordinarily comprises | The Background of the Invention ordinarily comprises | ||
Line 1,184: | Line 1,655: | ||
patent classification definitions. The statement should | patent classification definitions. The statement should | ||
be directed to the subject matter of the claimed invention. | be directed to the subject matter of the claimed invention. | ||
(2) Description of the related art including information | (2) Description of the related art including information | ||
Line 1,194: | Line 1,666: | ||
art or other information disclosed which are solved by | art or other information disclosed which are solved by | ||
the applicant’s invention should be indicated. See also | the applicant’s invention should be indicated. See also | ||
MPEP § 608.01(a), § 608.01(p) and § | MPEP § 608.01(a), § 608.01(p) and § | ||
707.05(b). | |||
608.01(d)Brief Summary of Invention | |||
37 CFR 1.73. Summary of the invention. | |||
A brief summary of the invention indicating its nature and substance, | A brief summary of the invention indicating its nature and substance, | ||
which may include a statement of the object of the invention, | which may include a statement of the object of the invention, | ||
Line 1,205: | Line 1,680: | ||
claimed and any object recited should be that of the invention as | claimed and any object recited should be that of the invention as | ||
claimed. | claimed. | ||
Since the purpose of the brief summary of invention | Since the purpose of the brief summary of invention | ||
Line 1,217: | Line 1,690: | ||
patents. That is, the subject matter of the | patents. That is, the subject matter of the | ||
invention should be described in one or more clear, | invention should be described in one or more clear, | ||
concise sentences or paragraphs. | concise sentences or paragraphs. Stereotyped general | ||
statements that would fit one application as well as | |||
another serve no useful purpose and may well be | |||
required to be canceled as surplusage, and, in the | |||
absence of any illuminating statement, replaced by | |||
statements that are directly on point as applicable | |||
exclusively to the case at hand. | |||
The brief summary, if properly written to set out the | |||
exact nature, operation, and purpose of the invention, | |||
will be of material assistance in aiding ready understanding | |||
of the patent in future searches. The brief | |||
summary should be more than a mere statement of the | |||
objects of the invention, which statement is also permissible | |||
under 37 CFR 1.73. | |||
The brief summary of invention should be consistent | |||
with the subject matter of the claims. Note final | |||
review of application and preparation for issue, | |||
MPEP § 1302. | |||
608.01(e)Reservation Clauses Not Permitted | |||
37 CFR 1.79. Reservation clauses not permitted. | |||
A reservation for a future application of subject matter disclosed | A reservation for a future application of subject matter disclosed | ||
but not claimed in a pending application will not be permitted | but not claimed in a pending application will not be permitted | ||
Line 1,228: | Line 1,722: | ||
application of the same applicant or owned by a common assignee | application of the same applicant or owned by a common assignee | ||
disclosing and claiming that subject matter. | disclosing and claiming that subject matter. | ||
608.01(f)Brief Description of Drawings | |||
[R-3] | |||
37 CFR 1.74. Reference to drawings. | |||
When there are drawings, there shall be a brief description of | When there are drawings, there shall be a brief description of | ||
the several views of the drawings and the detailed description of | the several views of the drawings and the detailed description of | ||
Line 1,239: | Line 1,733: | ||
numbers of the figures, and to the different parts by use of reference | numbers of the figures, and to the different parts by use of reference | ||
letters or numerals (preferably the latter). | letters or numerals (preferably the latter). | ||
The Office of Initial Patent Examination (OIPE) | |||
will review the specification, including the brief | |||
description, to determine whether all of the figures of | |||
If the specification describes a figure which is not | drawings described in the specification are present. If | ||
the specification describes a figure which is not | |||
present in the drawings, the application will be treated | present in the drawings, the application will be treated | ||
as an application filed without all figures of drawings | as an application filed without all figures of drawings | ||
in accordance with MPEP § 601.01(g), unless the | in accordance with MPEP § | ||
application lacks any drawings, in which case the | |||
601.01(g), unless the | |||
application lacks any drawings, in | |||
which case the | |||
application will be treated as an application filed | application will be treated as an application filed | ||
without drawings in accordance with MPEP | without drawings in accordance with MPEP | ||
§ 601.01(f). | § | ||
601.01(f). | |||
The examiner should see to it that the figures are | |||
correctly described in the brief description of the | |||
drawing, that all section lines used are referred to, and | |||
that all needed section lines are used. If a figure contains | |||
several parts, for example, figure 1A, 1B, and | |||
1C, the figure may be described as figure 1. If only | |||
figure 1A is described in the brief description, the | |||
examiner should object to the brief description, and | |||
require applicant to either add a brief description of | |||
figure 1B and 1C or describe the figure as “figure 1.” | |||
The specification must contain or be amended to | |||
contain proper reference to the existence of drawings | |||
executed in color as required by 37 CFR 1.84. | |||
37 CFR 1.84. Standards for drawings. | |||
(a)Drawings. There are two acceptable categories for presenting | (a)Drawings. There are two acceptable categories for presenting | ||
drawings in utility and design patent applications. | drawings in utility and design patent applications. | ||
(1)Black ink. Black and white drawings are normally | |||
required. India ink, or its equivalent that secures solid black lines, | required. India ink, or its equivalent that secures solid black lines, | ||
must be used for drawings; or | must be used for drawings; or | ||
(2)Color. On rare occasions, color drawings may be necessary | |||
as the only practical medium by which to disclose the subject | as the only practical medium by which to disclose the subject | ||
matter sought to be patented in a utility or design patent | matter sought to be patented in a utility or design patent | ||
Line 1,271: | Line 1,796: | ||
and statutory invention registrations only after granting a | and statutory invention registrations only after granting a | ||
petition filed under this paragraph explaining why the color drawings | petition filed under this paragraph explaining why the color drawings | ||
are necessary. Any such petition must include the following: | are necessary. Any such petition must include the following: | ||
(i)The fee set forth in § 1.17(h); | |||
(ii)Three (3) sets of color drawings; | |||
(iii)An amendment to the specification to insert | |||
(unless the specification contains or has been previously amended | (unless the specification contains or has been previously amended | ||
to contain) the following language as the first paragraph of the | to contain) the following language as the first paragraph of the | ||
brief description of the drawings: | brief description of the drawings: | ||
The patent or application file contains at least one drawing | The patent or application file contains at least one drawing | ||
Line 1,289: | Line 1,814: | ||
(b)Photographs.— | (b)Photographs.— | ||
(1)Black and white. Photographs, including photocopies | |||
of photographs, are not ordinarily permitted in utility and design | of photographs, are not ordinarily permitted in utility and design | ||
patent applications. The Office will accept photographs in utility | patent applications. The Office will accept photographs in utility | ||
Line 1,304: | Line 1,829: | ||
drawing in place of the photograph. The photographs must be of | drawing in place of the photograph. The photographs must be of | ||
sufficient quality so that all details in the photographs are reproducible | sufficient quality so that all details in the photographs are reproducible | ||
in the printed patent. | in the printed patent. | ||
(2)Color photographs. Color photographs will be | |||
accepted in utility and design patent applications if the conditions | accepted in utility and design patent applications if the conditions | ||
for accepting color drawings and black and white photographs | for accepting color drawings and black and white photographs | ||
have been satisfied. See paragraphs (a)(2) and (b)(1) of this section. | have been satisfied. See paragraphs (a)(2) and (b)(1) of this section. | ||
608.01(g)Detailed Description of Invention | |||
A detailed description of the invention and drawings | A detailed description of the invention and drawings | ||
Line 1,341: | Line 1,867: | ||
The description is a dictionary for the claims and | The description is a dictionary for the claims and | ||
should provide clear support or antecedent basis for | should provide clear support or antecedent basis for | ||
all terms used in the claims. See 37 CFR 1.75, MPEP | all terms used in the claims. See 37 CFR 1.75, MPEP | ||
§ 608.01(i), § 608.01(o), and § 1302.01. | § 608.01(i), § | ||
608.01(o), and § 1302.01. | |||
For completeness, see MPEP § 608.01(p). | For completeness, see MPEP § 608.01(p). | ||
USE OF SYMBOL “Phi” IN PATENT APPLICATION | |||
The Greek letter “Phi” has long been used as a symbol | |||
in equations in all technical disciplines. It further | |||
has special uses which include the indication of an | |||
electrical phase or clocking signal as well as an angular | |||
measurement. The recognized symbols for the | |||
upper and lower case Greek Phi characters, however, | |||
do not appear on most typewriters. This apparently | |||
has led to the use of a symbol composed by first striking | |||
a zero key and then backspacing and striking the | |||
“cancel” or “slash” key to result in an approximation | |||
of accepted symbols for the Greek character Phi. In | |||
other instances, the symbol is composed using the | |||
upper or lower case letter “O” with the “cancel” or | |||
“slash” superimposed thereon by backspacing, or it is | |||
simply handwritten in a variety of styles. These expedients | |||
result in confusion because of the variety of | |||
type sizes and styles available on modern typewriters. | |||
In recent years, the growth of data processing has | |||
seen the increasing use of this symbol (“Ø”) as the | |||
standard representation of zero. The “slashed” or | |||
“canceled” zero is used to indicate zero and avoid | |||
confusion with the upper case letter “O” in both text | |||
and drawings. | |||
Thus, when the symbol “Ø” in one of its many variations, | |||
as discussed above, appears in patent applications | |||
being prepared for printing, confusion as to the | |||
intended meaning of the symbol arises. Those (such | |||
as examiners, attorneys, and applicants) working in | |||
the art can usually determine the intended meaning of | |||
this symbol because of their knowledge of the subject | |||
matter involved, but editors preparing these applications | |||
for printing have no such specialized knowledge | |||
and confusion arises as to which symbol to print. The | |||
result, at the very least, is delay until the intended | |||
meaning of the symbol can be ascertained. | |||
Since the Office does not have the resources to conduct | |||
a technical editorial review of each application | |||
before printing, and in order to eliminate the problem | |||
of printing delays associated with the usage of these | |||
symbols, any question about the intended symbol will | |||
be resolved by the editorial staff of the Office of | |||
Patent Publication by printing the symbol Ø whenever | |||
that symbol is used by the applicant. Any Certificate | |||
of Correction necessitated by the above practice will | |||
be at the patentee’s expense (37 CFR 1.323) because | |||
the intended symbol was not accurately presented by | |||
the Greek upper or lower case Phi letters in the patent | |||
application. | |||
608.01(h)Mode of Operation of Invention | |||
The best mode contemplated by the inventor of carrying | The best mode contemplated by the inventor of carrying | ||
Line 1,353: | Line 1,942: | ||
requirement for the disclosure of a specific example. | requirement for the disclosure of a specific example. | ||
A patent specification is not intended nor required to | A patent specification is not intended nor required to | ||
be a production specification. | be a production specification. Spectra-Physics, Inc. v. | ||
Coherent, Inc., 827 F.2d 1524, 1536, 3 USPQ2d 1737, | |||
The absence of a specific | 1745 (Fed. Cir. 1987); In re Gay, 309 F.2d 769, 135 | ||
USPQ 311 (CCPA 1962). The absence of a specific | |||
working example is not necessarily evidence that the | working example is not necessarily evidence that the | ||
best mode has not been disclosed, nor is the presence | best mode has not been disclosed, nor is the presence | ||
of one evidence that it has. | of one evidence that it has. In re Honn, 364 F.2d 454, | ||
150 USPQ 652 (CCPA 1966). In determining the adequacy | |||
of a best mode disclosure, only evidence of | |||
concealment (accidental or intentional) is to be considered. | |||
That evidence must tend to show that the | |||
quality of an applicant’s best mode disclosure is so | |||
poor as to effectively result in concealment. Spectra- | |||
Physics, Inc. v. Coherent, Inc., 827 F.2d 1524, 1536, 3 | |||
USPQ2d 1737, 1745 (Fed. Cir. 1987); In re Sherwood, | |||
613 F.2d 809, 204 USPQ 537 (CCPA 1980). | |||
The question of whether an inventor has or has not | |||
disclosed what he or she feels is his or her best mode | |||
is a question separate and distinct from the question of | |||
sufficiency of the disclosure. Spectra-Physics, Inc. v. | |||
Coherent, Inc., 827 F.2d 1524, 1532, 3 USPQ2d 1737, | |||
1742 (Fed. Cir. 1987); In re Glass, 492 F.2d 1228, 181 | |||
USPQ 31 (CCPA 1974); In re Gay, 309 F.2d 769, 135 | |||
USPQ 311 (CCPA 1962). See 35 U.S.C. 112 and 37 | |||
CFR 1.71(b). | |||
If the best mode contemplated by the inventor at the | If the best mode contemplated by the inventor at the | ||
time of filing the application is not disclosed, such | time of filing the application is not disclosed, such | ||
defect cannot be cured by submitting an | defect cannot be cured by submitting an | ||
amendment seeking to put into the specification | amendment | ||
seeking to put into the specification | |||
something required to be there when the application | something required to be there when the application | ||
was originally filed. Any proposed amendment | was originally filed. In re Hay, 534 F.2d 917, 189 | ||
USPQ 790 (CCPA 1976). Any proposed amendment | |||
of this type should be treated as new matter. | of this type should be treated as new matter. | ||
Patents have been held invalid in cases where the | Patents have been held invalid in cases where the | ||
patentee did not disclose the best mode known to him | patentee did not disclose the best mode known to him | ||
or her. | |||
or her. See Chemcast Corp. v. Arco Indus. Corp., 913 | |||
F.2d 923. 16 USPQ2d 1033 (Fed. Cir. 1990); Dana | |||
Corp. v. IPC Ltd. Partnership, 860 F.2d 415, 8 | |||
USPQ2d 1692 (Fed. Cir. 1988); Spectra-Physics, Inc. | |||
v. Coherent, Inc., 821 F.2d 1524, 3 USPQ2d 1737 | |||
(Fed. Cir. 1987). | |||
For completeness, see MPEP § 608.01(p) and § | For completeness, see MPEP § 608.01(p) and § | ||
2165 to § 2165.04. | 2165 to § 2165.04. | ||
608.01(i)Claims [R-3] | |||
37 CFR 1.75. Claims | |||
(a) The specification must conclude with a claim particularly | |||
(a)The specification must conclude with a claim particularly | |||
pointing out and distinctly claiming the subject matter which | pointing out and distinctly claiming the subject matter which | ||
the applicant regards as his invention or discovery. | the applicant regards as his invention or discovery. | ||
(b) More than one claim may be presented provided they differ | (b)More than one claim may be presented provided they differ | ||
substantially from each other and are not unduly multiplied. | substantially from each other and are not unduly multiplied. | ||
(c) One or more claims may be presented in dependent | (c)One or more claims may be presented in dependent | ||
form, referring back to and further limiting another claim or | form, referring back to and further limiting another claim or | ||
claims in the same application. Any dependent claim which refers | claims in the same application. Any dependent claim which refers | ||
to more than one other claim ( | to more than one other claim (“multiple dependent claim”) shall | ||
refer to such other claims in the alternative only. A multiple | refer to such other claims in the alternative only. A multiple | ||
dependent claim shall not serve as a basis for any other multiple | dependent claim shall not serve as a basis for any other multiple | ||
Line 1,406: | Line 2,029: | ||
to which it is being considered. | to which it is being considered. | ||
(d) | (d)(1)The claim or claims must conform to the invention as | ||
set forth in the remainder of the specification and the terms and | set forth in the remainder of the specification and the terms and | ||
phrases used in the claims must find clear support or antecedent | phrases used in the claims must find clear support or antecedent | ||
basis in the description so that the meaning of the terms in the | basis in the description so that the meaning of the terms in the | ||
claims may be ascertainable by reference to the description (See § | claims may be ascertainable by reference to the description (See § | ||
1.58(a).) | 1.58(a).) | ||
(2)See §§ 1.141 to 1.146 as to claiming different inventions | |||
in one application. | in one application. | ||
(e) Where the nature of the case admits, as in the case of an | (e)Where the nature of the case admits, as in the case of an | ||
improvement, any independent claim should contain in the following | improvement, any independent claim should contain in the following | ||
order: | order: | ||
(1)A preamble comprising a general description of all the | |||
elements or steps of the claimed combination which are conventional | elements or steps of the claimed combination which are conventional | ||
or known, | or known, | ||
(2)A phrase such as “wherein the improvement comprises,” | |||
and | and | ||
(3)Those elements, steps, and/or relationships which | |||
constitute that portion of the claimed combination which the | constitute that portion of the claimed combination which the | ||
applicant considers as the new or improved portion. | applicant considers as the new or improved portion. | ||
(f) If there are several claims, they shall be numbered consecutively | (f)If there are several claims, they shall be numbered consecutively | ||
in Arabic numerals. | in Arabic numerals. | ||
(g) The least restrictive claim should be presented as claim | (g)The least restrictive claim should be presented as claim | ||
number 1, and all dependent claims should be grouped together | number 1, and all dependent claims should be grouped together | ||
with the claim or claims to which they refer to the extent practicable. | with the claim or claims to which they refer to the extent practicable. | ||
(h) The claim or claims must commence on a separate physical | |||
(h)The claim or claims must commence on a separate physical | |||
sheet or electronic page. Any sheet including a claim or portion | sheet or electronic page. Any sheet including a claim or portion | ||
of a claim may not contain any other parts of the application | of a claim may not contain any other parts of the application | ||
or other material. | or other material. | ||
(i) Where a claim sets forth a plurality of elements or steps, | (i)Where a claim sets forth a plurality of elements or steps, | ||
each element or step of the claim should be separated by a line | each element or step of the claim should be separated by a line | ||
indentation. | indentation. | ||
For numbering of claims, see MPEP § 608.01(j). | For numbering of claims, see MPEP § 608.01(j). | ||
Line 1,461: | Line 2,081: | ||
For claims in excess of fee, see MPEP § 714.10. | For claims in excess of fee, see MPEP § 714.10. | ||
608.01(j)Numbering of Claims | |||
37 CFR 1.126. Numbering of claims. | |||
The original numbering of the claims must be preserved | The original numbering of the claims must be preserved | ||
throughout the prosecution. When claims are canceled the remaining | throughout the prosecution. When claims are canceled the remaining | ||
Line 1,473: | Line 2,094: | ||
claims consecutively in the order in which they appear or in such | claims consecutively in the order in which they appear or in such | ||
order as may have been requested by applicant. | order as may have been requested by applicant. | ||
In a single claim case, the claim is not numbered. | |||
Form paragraph 6.17 may be used to notify applicant. | |||
¶ 6.17 Numbering of Claims, 37 CFR 1.126 | |||
The numbering of claims is not accordance with 37 CFR | |||
1.126, which requires the original numbering of the claims to be | |||
preserved throughout the prosecution. When claims are canceled, | |||
the remaining claims must not be renumbered. When new claims | |||
are presented, they must be numbered consecutively beginning | |||
with the number next following the highest numbered claims previously | |||
presented (whether entered or not). | |||
Misnumbered claim [1] been renumbered [2]. | |||
Examiner Note: | |||
1.In bracket 1, insert appropriate claim number(s) and --has-- | |||
or -- have --. | |||
2.In bracket 2, insert correct claim number(s) and --, respectively | |||
-- if more than one claim is involved. | |||
608.01(k)Statutory Requirement of | |||
Claims | |||
35 U.S.C. 112 requires that the applicant shall particularly | 35 U.S.C. 112 requires that the applicant shall particularly |